Dupixent Lawsuit Dupixent lawsuits are being investigated for patients who developed rare blood cancers such as cutaneous T-cell lymphoma (CTCL) after receiving injections, alleging that Sanofi and Regeneron failed to warn about the potential risks of immune suppression and delayed cancer diagnosis.
Tabletop Fire Pit Lawsuit Individuals who suffered severe burns, or families who lost a loved one in a tabletop fire pit explosion, may be eligible for financial compensation through a fire pit injury lawsuit.
Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Ozempic Gastroparesis Lawsuit Filed Over Nausea, Severe Abdominal Pain More than 1,600 similar GLP-1 lawsuits have been brought over gastrointestinal problems associated with the new class of diabetes drugs, which are also widely used as weight loss treatments. April 4, 2025 Irvin Jackson Add Your Comments An Oklahoma woman has filed a lawsuit against Ozempic manufacturers, alleging that after three years of using the popular diabetes treatment, which is also frequently used as a weight loss drug, she developed gastrointestinal side effects that led to her development of painful and debilitating stomach paralysis. The complaint (PDF) was brought by Jessica Wilson in the U.S. District Court for the Eastern District of Pennsylvania on March 28, where hundreds of similar lawsuits over Ozempic-related gastroparesis have been brought against Novo Nordisk and other manufacturers of GLP-1 receptor agonists, which are a class of drugs that includes Ozempic, Wegovy, Mounjaro, Zepbound and others, alleging the drug makers failed to adequately warn about the risk of severe gastrointestinal side effects. Originally approved as a type 2 diabetes treatment, aggressive advertisements that promoted Ozempic (semaglutide) weight loss benefits has led to it increasingly being prescribed as a diet drug, which eventually resulted in a weight loss-specific version, Wegovy, also manufactured by Novo Nordisk. Although promoted as safe and effective, with few long-term side effects, there have been a rising number of reports from users indicating they developed severe gastrointestinal issues such as stomach paralysis, or gastroparesis, after taking Ozempic and Wegovy. Like Wilson, hundreds of former individuals are now pursuing Ozempic lawsuits and Wegovy lawsuits against Novo Nordisk, as well as Mounjaro lawsuits against Eli Lilly. Each of the claims present similar allegations that users developed painful and debilitating stomach problems, which could have been avoided if the drug makers had not provided false and misleading information to patients and the medical community. Find Out If You Have a Lawsuit Were you prescribed Ozempic, Wegovy or Mounjaro? Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects Learn More SEE IF YOU QUALIFY FOR COMPENSATION Find Out If You Have a Lawsuit Were you prescribed Ozempic, Wegovy or Mounjaro? Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects Learn More SEE IF YOU QUALIFY FOR COMPENSATION According to her lawsuit, Wilson began using Ozempic in the fall of 2019 as a type 2 diabetes treatment. She received the injections for three years, until she began suffering from persistent and severe abdominal pain, nausea and vomiting in the fall of 2022. After undergoing a gastric emptying test, Wilson was diagnosed with gastroparesis and ended her use of Ozempic. The lawsuit argues that Wilson’s injuries were due to Novo Nordisk consciously downplaying the drug’s potential adverse side effects. “At all relevant times, Defendants knew, or in the exercise of reasonable care, should have known that the use of Ozempic could cause Plaintiff’s injuries and, thus, created a dangerous and unreasonable risk of injury to Plaintiff and other users of this product for which Defendants did not warn,” the lawsuit states. “Defendants knew or in the exercise of reasonable care should have known that users and consumers were unaware of the risks and magnitude of the risks associated with the use of Ozempic.” Wilson presents claims of negligence, failure to warn, design defect, negligent misrepresentation and marketing, breach of warranty, fraudulent concealment, fraudulent misrepresentation, and violation of the Oklahoma Consumer Protection Act. She seeks both compensatory and punitive damages. April 2025 Ozempic Lawsuits Update Given common questions of fact and law raised in complaints brought throughout the federal court system, Wilson’s Ozempic gastroparesis lawsuit will be centralized with all GLP-1 lawsuits as part of a multidistrict litigation (MDL) in the Eastern District of Pennsylvania, where they are currently being overseen by U.S. District Judge Karen Marston. Before beginning a series of early “bellwether” test trials, Judge Marston has tasked the parties with addressing a number of “cross-cutting” issues, including whether claims are preempted by federal law, whether plaintiffs are required to present specific diagnostic testing evidence to substantiate their injuries, and whether there is sufficient general causation evidence linking Ozempic and the gastrointestinal injuries. Once those factors are resolved, Judge Marston is expected to move forward with scheduling the bellwether trials, which will test how juries may respond to certain evidence and testimony that may be repeated throughout thousands of individual claims. While the outcomes of these early test cases will not be binding on other claims, they will be closely watched and may help the parties negotiate GLP-1 settlements to resolve large numbers of lawsuits in the future. Find Out If You Qualify for Ozempic or Wegovy Compensation Tags: Diabetes, Gastroparesis, GLP-1, Nausea, Novo Nordisk, Ozempic, Stomach Paralysis, Vomiting, Weight Loss Image Credit: Shutterstock: Marc Bruxelle Written By: Irvin Jackson Senior Legal Journalist & Contributing Editor Irvin Jackson is a senior investigative reporter at AboutLawsuits.com with more than 30 years of experience covering mass tort litigation, environmental policy, and consumer safety. He previously served as Associate Editor at Inside the EPA and contributes original reporting on product liability lawsuits, regulatory failures, and nationwide litigation trends. More Ozempic, Wegovy and Mounjaro Stories Woman Files Trulicity and Ozempic Lawsuit Over Ileus, Intestinal Obstruction September 5, 2025 GLP-1 Side Effects May Increase Kidney Cancer Risks: Study September 3, 2025 MDL Sought for GLP-1 NAION Lawsuits Against Ozempic, Wegovy, Mounjaro Manufacturers August 29, 2025 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermFacebookThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Wayfair Fire Pit Lawsuit Links Flame Jetting Explosion to Defective Design (Posted: 2 days ago) In March 2026, a jury is scheduled to hear a Wayfair fire pit lawsuit from a woman who suffered burns to nearly half her body. MORE ABOUT: TABLETOP FIRE PIT LAWSUITAmazon Tabletop Fire Pit Lawsuit Alleges ‘Flame-Jetting’ Caused Third Degree Burns (08/29/2025)Tabletop Fire Pit Burn Victims Share Stories of Explosions and Devastating Injuries (08/21/2025)Colsen Fire Pit Lawsuit Involving Severe Burn Injuries Suffered by a Child Set for Trial Next Year (08/14/2025) Dupixent T-Cell Lymphoma Lawsuits May Follow Recent Studies Linking Drug to Cancer Risks (Posted: 3 days ago) Dupixent lawsuits are now being investigated after studies and FDA reports link Dupixent (dupilumab) to cutaneous T-cell lymphoma (CTCL). MORE ABOUT: DUPIXENT LAWSUITDupixent Side Effects May Increase Cutaneous T-Cell Lymphoma (CTCL) Risks (08/26/2025) Depo-Provera Meningioma Side Effects Significantly Increased Among Women Over 31: Study (Posted: 4 days ago) A new study appears to further confirm and quantify the risks of Depo-Provera meningioma side effects, potentially providing further evidence for growing litigation. MORE ABOUT: DEPO-PROVERA LAWSUITPfizer Seeks Dismissal of Depo-Provera Failure-To-Warn Lawsuits Over Meningioma Risks (09/02/2025)Nearly 1,000 Depo-Provera Meningioma Lawsuits Filed, With Another 9,500 Under Investigation (08/25/2025)Experts Weigh In On Depo-Provera Brain Tumor Risks, As Lawsuits Continue to Mount (08/20/2025)
Wayfair Fire Pit Lawsuit Links Flame Jetting Explosion to Defective Design (Posted: 2 days ago) In March 2026, a jury is scheduled to hear a Wayfair fire pit lawsuit from a woman who suffered burns to nearly half her body. MORE ABOUT: TABLETOP FIRE PIT LAWSUITAmazon Tabletop Fire Pit Lawsuit Alleges ‘Flame-Jetting’ Caused Third Degree Burns (08/29/2025)Tabletop Fire Pit Burn Victims Share Stories of Explosions and Devastating Injuries (08/21/2025)Colsen Fire Pit Lawsuit Involving Severe Burn Injuries Suffered by a Child Set for Trial Next Year (08/14/2025)
Dupixent T-Cell Lymphoma Lawsuits May Follow Recent Studies Linking Drug to Cancer Risks (Posted: 3 days ago) Dupixent lawsuits are now being investigated after studies and FDA reports link Dupixent (dupilumab) to cutaneous T-cell lymphoma (CTCL). MORE ABOUT: DUPIXENT LAWSUITDupixent Side Effects May Increase Cutaneous T-Cell Lymphoma (CTCL) Risks (08/26/2025)
Depo-Provera Meningioma Side Effects Significantly Increased Among Women Over 31: Study (Posted: 4 days ago) A new study appears to further confirm and quantify the risks of Depo-Provera meningioma side effects, potentially providing further evidence for growing litigation. MORE ABOUT: DEPO-PROVERA LAWSUITPfizer Seeks Dismissal of Depo-Provera Failure-To-Warn Lawsuits Over Meningioma Risks (09/02/2025)Nearly 1,000 Depo-Provera Meningioma Lawsuits Filed, With Another 9,500 Under Investigation (08/25/2025)Experts Weigh In On Depo-Provera Brain Tumor Risks, As Lawsuits Continue to Mount (08/20/2025)